PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: Consistent pain reduction and improvement in function data, page-2

  1. 4,258 Posts.
    lightbulb Created with Sketch. 6741
    https://hotcopper.com.au/data/attachments/2866/2866686-01fafe8d4079a5ec1cb0f9b821085eea.jpg


    I've added the emphasis...key points for me

    1) Great additional data, adds to the set nicely.
    2) CONSISTENCY, very important
    3) Safety first - No AE's reported in last batch
    4) Affirmation Q3 SAS Revenue (maybe modest, but still revenue) is possible in this area.
    Last edited by Mozzarc: 03/02/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.